Circulating HER-2 mRNA in the peripheral blood as a potential diagnostic and prognostic biomarker in females with breast cancer

Breast cancer is a prevalent malignant cancer worldwide, and a lack of defined biomarkers for early prognostication contributes to its high associated mortality rate, especially in human epidermal growth factor receptor 2 (HER-2)-positive breast cancer. In the present study, HER-2 mRNA levels in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yanlin, Meng, Qiping, Yang, Zhixue, Shi, Lili, Hu, Rongkuan, Zhang, Peizhuo, Wei, Jinrong, Ren, Jie, Leng, Bingjing, Xu, Dong, Jiang, Guo-Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096115/
https://www.ncbi.nlm.nih.gov/pubmed/30127983
http://dx.doi.org/10.3892/ol.2018.9091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096115/
https://www.ncbi.nlm.nih.gov/pubmed/30127983
http://dx.doi.org/10.3892/ol.2018.9091

Ejemplares similares